Vivani Medical VANI Proceeds From Issuance Of Common Stock In Connection With Private Placement Net Of Issuance Costs
Proceeds From Issuance Of Common Stock In Connection With Private Placement Net Of Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept vani:ProceedsFromIssuanceOfCommonStockInConnectionWithPrivatePlacementNetOfIssuanceCosts.
The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's proceeds from issuance of common stock in connection with private placement net of issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's proceeds from issuance of common stock in connection with private placement net of issuance costs?
- Vivani Medical (VANI) reported proceeds from issuance of common stock in connection with private placement net of issuance costs of $2M in Q1 2026.
- How has Vivani Medical's proceeds from issuance of common stock in connection with private placement net of issuance costs changed year-over-year?
- Vivani Medical's proceeds from issuance of common stock in connection with private placement net of issuance costs increased by 33.1% year-over-year, from $1.5M to $2M.
- What does proceeds from issuance of common stock in connection with private placement net of issuance costs mean?
- This metric tracks the net cash proceeds from private placement transactions involving the sale of common stock to a select group of investors. It highlights the company's access to private capital markets to bridge funding gaps during preclinical or clinical development stages.